GENEVA, Sept. 24 -- INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE filed a patent application (EP2026/057614) for “GENOTYPING THE TPSAB1 LOCUS FOR PREDICTING BOTH OVERALL SURVIVAL AND OVERALL RESPONSE IN CANCER PATIENTS”. With publication no. WO/2026/195725, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12Q 1/6886
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....